Abstract
Aims
To explore the trend in prescribing of drugs classified within the R03 therapeutic pharmacological subgroup (drugs for obstructive airway diseases) of the Anatomical Therapeutic Chemical (ATC) classification.
Methods
Comparison of GP-collected data on physician-patient contacts and drug prescriptions for asthma and COPD in 2006 and 2008.
Results
Compared to 2006, in 2008 patients with COPD were prescribed more long-acting bronchodilators; use of tiotropium increased, whilst use of long-acting β2-agonists (LABAs) and short-acting antimuscarinic agents decreased. However, 55.9% of patients in 2006, and 47.8% in 2008, received an inhaled corticosteroid (ICS), mainly as a LABA/ICS fixed combination inhaler. Compared to 2006, in 2008 there were increased prescriptions of LABA/ICS fixed combination inhalers for asthma, but only 54.5% of all prescriptions included an ICS. This could explain the large use of short-acting β2-agonists, a marker of poor asthma control. Remarkably, LABA/ICS fixed combination inhalers were prescribed more frequently in COPD than in asthma.
Conclusions
Our data indicate that adherence to guidelines is still low. Patients with asthma and COPD are undertreated by Italian GPs, with a trend to a change in COPD prescribing likely driven by new scientific information.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Contributions
The original idea for the study was formulated by Prof. Cazzola, with subsequent advice from Drs. Bettoncelli and Cricelli, and statistical input from Dr. Calzetta, who also performed the statistical analyses. Prof. Cazzola drafted the manuscript, with extensive contributions and revision from all authors.
Corresponding author
Ethics declarations
Competing interests
The authors have no significant conflicts of interest with any company or organisation whose products or services are discussed in this article.
Rights and permissions
About this article
Cite this article
Cazzola, M., Segreti, A., Bettoncelli, G. et al. Change in asthma and COPD prescribing by Italian general practitioners between 2006 and 2008. Prim Care Respir J 20, 291–298 (2011). https://doi.org/10.4104/pcrj.2011.00033
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.4104/pcrj.2011.00033
This article is cited by
-
Improvement in the management of chronic obstructive pulmonary disease following a clinical educational program: results from a prospective cohort study in the Sicilian general practice setting
npj Primary Care Respiratory Medicine (2018)
-
Implementation of GOLD consensus report in real life: results from the Velletri-Lariano (VELA) cohort
Multidisciplinary Respiratory Medicine (2017)
-
Use of concomitant inhaled corticosteroids: pooled data from two phase III studies of aclidinium plus formoterol in COPD
npj Primary Care Respiratory Medicine (2017)
-
Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial
BMC Pulmonary Medicine (2015)
-
The efficacy and safety of inhaled corticosteroids: are we ignoring the potential advantages of ciclesonide?
npj Primary Care Respiratory Medicine (2014)